CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project develops ApTOLL, a novel drug aimed at reducing brain damage in patients with acute ischemic stroke. By targeting specific receptors, it seeks to improve treatment outcomes and enhance quality of life for stroke survivors.
Stroke is a devastating medical condition affecting 15 million people worldwide yearly, being Ischemic Stroke the most frequent (87%).
Indeed, the global cost of stroke is >847b (60b in EU) due to the huge socioeconomic burden of disabilities.
Reperfusion treatment improves outcomes, but only 20% of patients are currently eligible for treatment due to the narrow therapeutic window after stroke symptom onset and stringent selection criteria for eligibility.
Novel therapies - small molecules or bi…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
